drugset / Trial / NCT02646332

Comparing the Efficacy of Reverse Hybrid Therapy and Concomitant Therapy

NCT02646332

Completed 248 enrolled Kaohsiung Veterans General Hospital.
RandomizedParallel-groupOpen-labelTreatment

Summary

Reverse hybrid therapy achieves a higher eradication rate than concomitant therapy remains unanswered.

Timeline

Start
2015-12
Primary completion
2020-07-31
Completion
2020-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified 1 g
Subject Clarithromycin Small molecule 500 mg
Subject Dexlansoprazole Other / unclassified 60 mg
Subject Metronidazole Small molecule 500 mg